During Wednesday’s current trade, Mobileye NV (NYSE:MBLY)’s shares gained 7.89% to $45.69, as analysts at both Morgan Stanley and Deutsche Bank issued positive notes on the company earlier today.
Analysts at Morgan Stanley raised its price target to $68 on shares of the driver-assistance system maker, and said the time to own the stock is “now.”
Deutsche Bank also raised its price target for Mobileye shares to $55 from $53, while maintaining a “buy” rating.
The firm said the U.S. will likely adopt a more proactive stance on active safety technologies like Forward Crash Avoidance and Mitigation Systems. Deutsche analysts think FCAM growth will exceed its preceding assumptions.
Mobileye N.V., together with its auxiliaries, designs and develops software and related technologies for camera-based advanced driver assistance systems primarily in Israel. It operates through two segments, Original Equipment Manufacturing and After Market. The company offers proprietary software algorithms and EyeQ chips that perform detailed interpretations of the visual field to anticipate possible collisions with other vehicles, pedestrians, cyclists, animals, debris, and other obstacles; and detect roadway markings, such as lanes, road boundaries, barriers, and related items, in addition to identify and read traffic signs and traffic lights.
During mid-morning trade, Yahoo! Inc (NASDAQ:YHOO)’s shares raised 0.30% to $45.59.
According to Reuters, The Frankfurt-listed shares of Internet companies Yahoo and Facebook outperformed those of rival Google, after media reports that Google would face anti-trust action from the European Union.
The European Union will accuse Google Inc on Wednesday of abusing its dominant position in Internet searches, opening the U.S. tech company up to a risk of massive fines and enforced changes in its business model, stated the Financial Times and Wall Street Journal.
However, two sources familiar with the matter told Reuters that a formal antitrust charge sheet will not be ready for Wednesday and could take several more months to draw up. The EU can impose fines of up to 10 percent of global turnover, or more than $6 billion in penalties in Google’s case.
Yahoo! Inc. provides search and display advertising services on Yahoo properties and associate sites worldwide. The company offers Yahoo Search that serves as a starting point to navigate the Internet and discover information; and Yahoo Answers, which enables users to seek, discover, and share knowledge and opinions across mobile phones, tablets, and desktops. It also provides Yahoo Mail that connects users to the people and things; Yahoo Messenger, an instant messaging service; and Yahoo Groups, which allows users to join groups based on shared interests and involvements.
Hewlett-Packard Company (NYSE:HPQ), during its Wednesday’s current trading session jumped 1.85%, to $33.12.
Yesterday, Hewlett-Packard Company (HPQ), declared Antonio Lucio will become Chief Marketing Officer of HP Inc., the company comprising HP’s market-leading personal systems and printing businesses following HP’s separation into two new publicly traded Fortune 50 companies. In this role, Lucio will work alongside HP Inc.’s leadership team to drive sales and build brand loyalty as the company delivers innovations that empower people to create, interact and inspire like never before. Lucio will report to Dion Weisler, future Chief Executive Officer of HP Inc.
“Since announcing our plans to separate we have made great progress in designing how HP Inc. will operate in order to foster an entrepreneurial spirit that is built around innovation and quality,” said Dion Weisler, executive vice president, HP Printing & Personal Systems (PPS). “Antonio’s vision for a world-class marketing organization and comprehensive experience cultivating iconic global brands make him the perfect leader to join our team and take the HP Inc. mission forward.”
Lucio will join HP after spending eight years at Visa where he was most recently the Global Chief Brand Officer responsible for all global brand and product marketing and global communications. Lucio held the position of Chief Marketing Officer at Visa as they prepared for their IPO in 2008 and led the development of that brand’s first-ever global positioning and brand identity system.
Hewlett-Packard Company, together with its auxiliaries, provides products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses (SMBs), in addition to to the government, health, and education sectors worldwide. The company’s Personal Systems segment offers commercial personal computers (PCs), consumer PCs, workstations, thin clients, tablets, retail point-of-sale systems, calculators and other related accessories, software, support, and services for the commercial and consumer markets.
Merck & Co., Inc (NYSE:MRK), during its Wednesday’s current trading session rose 1.11%, to $58.40.
Yesterday, Merck (MRK), known as MSD outside the United States and Canada, and NewLink Genetics Corporation (NLNK), confirmed that the third, late-stage, clinical trial of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) has been initiated in Sierra Leone. The vaccine candidate was originally developed by the Public Health Agency of Canada’s National Microbiology Laboratory and licensed to NewLink Genetics in 2010. On Nov. 24, 2014, Merck and NewLink Genetics declared an exclusive licensing and partnership contract for the investigational Ebola vaccine.
The Phase II/ III safety and effectiveness study, called STRIVE (Sierra Leone Trial to Introduce a Vaccine against Ebola) taking place in Sierra Leone will involve 6,000 health and other frontline workers and is being led by the Sierra Leone College of Medicine and Allied Health Sciences, Sierra Leone Ministry of Health and Sanitation, and the U.S. Centers for Disease Control and Prevention (CDC).
“Fighting Ebola remains a global health priority, and Merck is committed to advancing the development of our and NewLink’s vaccine candidate as part of our overall response to the crisis,” said Mark Feinberg, M.D., Ph.D., chief public health and science officer, Merck Vaccines.
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
